Your browser doesn't support javascript.
loading
Inhibition of the Clostridioides difficile Class D ß-Lactamase CDD-1 by Avibactam.
Stewart, Nichole K; Toth, Marta; Stasyuk, Anastasiya; Lee, Mijoon; Smith, Clyde A; Vakulenko, Sergei B.
Afiliación
  • Stewart NK; Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556, United States.
  • Toth M; Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556, United States.
  • Stasyuk A; Stanford Synchrotron Radiation Lightsource, Stanford University, Menlo Park, California 94025, United States.
  • Lee M; Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556, United States.
  • Smith CA; Stanford Synchrotron Radiation Lightsource, Stanford University, Menlo Park, California 94025, United States.
  • Vakulenko SB; Department of Chemistry, Stanford University, Stanford, California 94305, United States.
ACS Infect Dis ; 7(5): 1164-1176, 2021 05 14.
Article en En | MEDLINE | ID: mdl-33390002
Avibactam is a potent diazobicyclooctane inhibitor of class A and C ß-lactamases. The inhibitor also exhibits variable activity against some class D enzymes from Gram-negative bacteria; however, its interaction with recently discovered class D ß-lactamases from Gram-positive bacteria has not been studied. Here, we describe microbiological, kinetic, and mass spectrometry studies of the interaction of avibactam with CDD-1, a class D ß-lactamase from the clinically important pathogen Clostridioides difficile, and show that avibactam is a potent irreversible mechanism-based inhibitor of the enzyme. X-ray crystallographic studies at three time-points demonstrate the rapid formation of a stable CDD-1-avibactam acyl-enzyme complex and highlight differences in the anchoring of the inhibitor by class D enzymes from Gram-positive and Gram-negative bacteria.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Beta-Lactamasas / Inhibidores de beta-Lactamasas Idioma: En Revista: ACS Infect Dis Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Beta-Lactamasas / Inhibidores de beta-Lactamasas Idioma: En Revista: ACS Infect Dis Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos